Concurrent Chemoradiotherapy Using Paclitaxel Plus Cisplatin in the Treatment of Elderly Patients With Esophageal Cancer

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s92537
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Long-Term Results of Definitive Concurrent Chemoradiotherapy Using S-1 in the Treatment of Geriatric Patients With Esophageal Cancer

OncoTargets and Therapy
OncologyPharmacology
2016English

PRO: Patients With Metastatic/Recurrent Cervical Cancer Should Be Treated With Cisplatin Plus Paclitaxel

Clinical Ovarian Cancer
2011English

P2.17-21 Efficacy of Concurrent Carboplatin-Paclitaxel Chemoradiotherapy With 66 Gy for Elderly Patients With Stage III Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

A Meta-Analysis of Concurrent Chemoradiotherapy for Advanced Esophageal Cancer

PLoS ONE
Multidisciplinary
2015English

Treatment of Limited-Stage Small Cell Lung Cancer in the Elderly, Chemotherapy vs. Sequential Chemoradiotherapy vs. Concurrent Chemoradiotherapy: That’s the Question

Translational Lung Cancer Research
Oncology
2016English

Effective Treatment of Anal Cancer in the Elderly With Low-Dose Chemoradiotherapy

British Journal of Cancer
Cancer ResearchOncology
2005English

Long-Term Follow-Up of a Randomized Phase II Study of Cisplatin/5-Fu Concurrent Chemoradiotherapy for Esophageal Cancer (KROSG0101/JROSG021)

Japanese Journal of Clinical Oncology
Nuclear MedicineRadiologyCancer ResearchOncologyImagingMedicine
2012English

Comparison Between Late‑course Accelerated Hyperfractionation Radiotherapy and Concurrent Chemoradiotherapy in Patients With Esophageal Carcinoma

Oncology Letters
Cancer ResearchOncology
2011English

Is Concurrent Chemoradiotherapy Also the Best Treatment for Elderly Patients With Limited-Stage Small Cell Lung Cancer? – What the CONVERT Data Can Tell Us

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy